País: Holanda
Língua: holandês
Origem: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
TIZANIDINEHYDROCHLORIDE 2,29 mg/stuk SAMENSTELLING overeenkomend met ; TIZANIDINE 2 mg/stuk
TIZANIDINEHYDROCHLORIDE 2,29 mg/stuk SAMENSTELLING overeenkomend met ; TIZANIDINE 2 mg/stuk
Tablet
LACTOSE 1-WATER ; MACROGOL 4000 ; MAGNESIUMSTEARAAT (E 470b) ; SACCHAROSE ; STEARINEZUUR (E 570) ; ZETMEEL, GEPREGELATINEERD
Oraal gebruik
1900-01-01
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT TIZAGELAN 2 MG TABLETTEN TIZAGELAN 4 MG TABLETTEN tizanidine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What [Tizanidine] is and what it is used for 2. What you need to know before you take [Tizanidine] 3. How to take [Tizanidine] 4. Possible side effects 5. How to store [Tizanidine] 6. Contents of the pack and other information 1. WHAT [TIZANIDINE] IS AND WHAT IT IS USED FOR [Tizanidine] belongs to a group of medicines called skeletal muscle relaxants. Tizanidine] can be prescribed by your doctor for muscle cramps caused by certain conditions of the spine or as a result of surgery on the musculoskeletal system (for example vertebrae or hip joint). [Tizanidine] can also be prescribed for muscle cramps as a result of disorders of the nervous system, such as multiple sclerosis and after a stroke. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE [TIZANIDINE] DO NOT TAKE [TIZANIDINE], - if you are allergic to tizanidine or any of the other ingredients of this medicine (listed in section 6). - if your liver function is severely impaired. - if you are taking certain medicines such as fluvoxamine (to treat depressions) or ciprofloxacin (an antibiotic) (see also ‘Other medicines and [Tizanidine]’). WARNINGS AND PRECAUTIONS Talk to your doctor before taking [Tizanidine], - if you have a severe kidney disease. You may require a lower dose. - if you have heart problems such as coronary artery disease. - if you have liver problems. Maybe your doctor will check your li Leia o documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAAM VAN HET GENEESMIDDEL Tizagelan 2 mg tabletten Tizagelan 4 mg tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION [Tizanidine] 2 mg tablets Each tablet contains 2 mg tizanidine (as 2.29 mg tizanidine hydrochloride). Excipients with known effect: Each tablet contains 106.79 mg lactose monohydrate and 11.76 mg sucrose. [Tizanidine] 4 mg tablets Each tablet contains 4 mg tizanidine (as 4.57 mg tizanidine hydrochloride). Excipients with known effect: Each tablet contains 104.51 mg lactose monohydrate and 11.76 mg sucrose. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet [Tizanidine] 2 mg tablets White to yellowish coloured, round and biconvex tablet, with a break score on one side and with a diameter of about 8 mm. The tablet can be divided into equal doses. [Tizanidine] 4 mg tablets White to yellowish coloured, round and biconvex tablet, with a cross break score on one side and with a diameter of about 8 mm. The tablet can be divided into equal doses, either halves or quarts. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS SPASMS OF THE SKELETAL MUSCLES - associated with static and functional disorders of the spine (cervical and lumbar syndromes) - after surgical interventions on the musculoskeletal system, e.g. herniated disc or joint disorders of the hip. SPASTICITY DUE TO NEUROLOGICAL DISORDERS, such as - multiple sclerosis, chronic myelopathy, degenerative spinal cord disease, cerebrovascular accidents and cerebral palsy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION [Tizanidine] has a narrow therapeutic index and a high inter-patient variability in tizanidine plasma concentrations. Therefore, it is important to adjust the dose individually. A low starting dose of 2 mg three times daily can reduce the risk of side effects. The dose should be increased gradually and with caution according to the individual patient’s need and the therapeutic response. Posology SPASMS OF THE SKELETAL MUSCLES The recommended dose is 2-4 mg 3 times daily. In Leia o documento completo